Other Consolidated Financial Statement Detail

Other Income (Expense), Net

Components of other income (expense), net, are summarized as follows:



	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
(In millions)	2014			2013			2014			2013
Interest income	$	3.6		$	1.5		$	8.7		$	6.7
Interest expense	(7.4		)	(6.6		)	(22.1		)	(25.5		)
Impairments of investments	—			—			—			(1.7		)
Gain (loss) on investments, net	(3.1		)	3.9			13.5			14.0
Foreign exchange gains (losses), net	(4.8		)	(3.1		)	(9.5		)	(11.0		)
Other, net	(4.6		)	(0.3		)	(7.6		)	(12.0		)
Total other income (expense), net	$	(16.3	)	$	(4.6	)	$	(17.0	)	$	(29.5	)

Accrued Expenses and Other

Accrued expenses and other consists of the following:



(In millions)	As of September 30, 2014		As of December 31, 2013
Revenue-related rebates	$	329.2	$	264.9
Employee compensation and benefits	323.3		343.4
Current portion of contingent consideration obligations	219.3		29.0
Royalties and licensing fees	173.0		160.7
Deferred revenue	110.0		172.7
Clinical development expenses	61.1		55.2
Collaboration expenses	31.0		18.7
Construction in progress accrual	21.1		25.0
Other	276.2		285.6
Total accrued expenses and other	$	1,544.2	$	1,355.2

Other Long-Term Liabilities

Other long-term liabilities includes long-term taxes payable totaling approximately $187.7 million and long-term employee compensation and benefits of $178.1 million.